All news

© Getty Images

Gene sequencing identifies rare pediatric disorders in Mexico

By Isabel Cameron

A new genetic sequencing technology from Element Biosciences has helped researchers from the Translational Genomics Research Institute (TGen), part of the City of Hope, identify the likely genetic causes of disorders in six of nine children from Sonora,...

© Getty Images

Sosei Heptares doses first patient in schizophrenia drug trial

By Isabel Cameron

Sosei Heptares has dosed the first subject in a phase 1 trial evaluating HTL’149, a first-in-class GPR52 agonist, which represents a novel mechanism of action for the treatment of schizophrenia and related neurological diseases.

© Getty Images

First patient dosed in Enterome’s metastatic colon cancer trial

By Isabel Cameron

Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases, has announced that the first patient has been dosed in its phase 1/2 trial evaluating EO4010.

© Getty Images

Donaldson acquires Univercells Technologies for €136 million

By Isabel Cameron

Donaldson, a provider of filtration products and solutions, has acquired Univercells Technologies, a producer of biomanufacturing solutions for cell and gene therapy research, development, and commercial manufacturing, to broaden its life sciences reach....

© Getty Images

SMi discloses £6 million seed funding round

By Isabel Cameron

SMi Systems, a company specializing in single molecule imaging and quantification technologies, has disclosed a £6m seed funding round to develop the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.

© Getty Images

Oliva Therapeutics partners with Rio Biopharmaceuticals

By Isabel Cameron

Oliva Therapeutics, a healthcare company focused on product commercialization, sales, marketing, distribution, and promotion, has announced its new long-term partnership with Rio Biopharmaceuticals, for the exclusive North American supply and distribution...

© Rentschler Biopharma

Rentschler Biopharma: ‘Our strength is in our niche’

By Isabel Cameron

As the global contract development and manufacturing organization (CDMO) market continues to grow, we caught up with Federico Pollano, SVP business development at Rentschler Biopharma, at Bio International 2023, to discuss the company's ongoing growth...